| |
Latest 10 SEC filings (by transaction date) for PCRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 8/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -90,000 | $30.60 |
Mar 8/24 | Mar 7/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -28,257 | $30.81 |
Mar 8/24 | Mar 6/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -1,066 | $29.67 |
Feb 7/24 | Feb 5/24 | Williams Kristen | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 33,700 | |
Feb 7/24 | Feb 5/24 | Gaugler Daryl | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 33,700 | |
Jan 4/24 | Jan 3/24 | Slonin Jonathan | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 4/24 | Jan 3/24 | Lee Frank D. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 692,512 | |
Jan 4/24 | Jan 2/24 | Riker Lauren | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -159 | $32.00 |
Jan 4/24 | Jan 2/24 | Slonin Jonathan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Jan 4/24 | Jan 2/24 | Lee Frank D. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 99,520 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PCRX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 8/24 | Mar 8/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -90,000 | $30.60 |
Mar 8/24 | Mar 7/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -28,257 | $30.81 |
Mar 8/24 | Mar 6/24 | Pace Gary W | Direct Ownership | Common Stock | S - Open market or private sale | -1,066 | $29.67 |
Feb 7/24 | Feb 5/24 | Williams Kristen | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 33,700 | |
Feb 7/24 | Feb 5/24 | Gaugler Daryl | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 33,700 | |
Jan 4/24 | Jan 2/24 | Riker Lauren | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -159 | $32.00 |
Jan 4/24 | Jan 3/24 | Slonin Jonathan | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Jan 4/24 | Jan 2/24 | Slonin Jonathan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Jan 4/24 | Jan 3/24 | Lee Frank D. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 692,512 | |
Jan 4/24 | Jan 2/24 | Lee Frank D. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 99,520 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |